 Market, Global Colorimetric Immunoassays (CI) Market.){kind=link}
The screening of donated blood and blood components represent critical processes that should be followed to make sure that blood units are safe. They should either be released for manufacturing use or be discarded. The research report, ‘(Blood Screening Market: Current Analysis and Forecast (2021-2027)’, aims to provide an in-depth overview and analysis of the market. The report states that some of the top leading vendors operating in the market are Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., bioMerieux, Inc., Grifols, S.A., Danaher Corporation, Boster Biological Technology, Demeditec Diagnostics GmbH, and others. This report has consolidated different parameters through which the above-stated companies exist and compete against each other. Some of these parameters are – the performance of the company, sales, risk analysis, collaborative business strategy, recent development, regional presence, acquisitions, and product and services offered by these companies. Along with this, the report comprises various insights made with the help of research methodologies like PESTEL analysis, SWOT analysis, and others. The report further includes company profiling of each player aforementioned and also reviews how far along the player stands in the competition.
The report mentions that the blood screening market is categorized into various segments. These segments are – Based on products types (Reagents & Kits, Instruments, Software & Services.), Based on technology (Nucleic Acid Amplification (NAAT), Enzyme Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blotting, Next Generation Sequencing (NGS)), Based on application (Hospitals, Blood Banks, Others), Based on the region (North America, Europe, Asia-Pacific, and Rest of World). The study discusses the forecast of each segment and sub-segments in detail. For instance- under the category of technology, NAAT sub-segment owns the major share of the blood screening market and is further expected to grow in the forecast period. Likewise, the report provides insights into various other segments. For a better understanding of the market, the report covers the market details for all the countries present in the above-stated regions as well. Some of these countries are – the United States, Canada, Germany, the UK, China, India, and many others.
Request For Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NDkzMjcx
In addition to that, the report also provides market trends for the blood screening market both in the present and future. The research report is equipped with various dimensions such as dynamics of the market both globally and region-wise, analysis of historical data, and technology development, strategies adopted by the aforementioned companies, and study of the market size (in terms of value and volume) based on demand and supply, market growth drivers, application details, market features, restraints, regional and industry wise investment opportunities and much more.
In the upcoming years, the blood screening market is anticipated to grow and reach a substantial value in terms of revenue in USD million by the end of the year 2027 at a double-digit CAGR during the forecast period (2021-2027). Factors like the rise in blood donations and blood transfusion-related screenings, growing prevalence of infectious diseases, are driving the growth of this market.
For More Information, refer to below link:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249